Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes

被引:26
作者
Goulder, PJR
Reid, SW
Price, DA
OCallaghan, CA
McMichael, AJ
Phillips, RE
Jones, EY
机构
[1] UNIV OXFORD,MOL BIOPHYS LAB,OXFORD OX1 3QU,ENGLAND
[2] OXFORD CTR MOL SCI,OXFORD OX1 3QY,ENGLAND
基金
英国惠康基金;
关键词
cytotoxic T lymphocyte; peptide presentation; epitope; HIV;
D O I
10.1002/eji.1830270630
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study demonstrates that use of structural information improves the definition and optimization of cytotoxic T lymphocyte (CTL) epitopes. Epitope optimization usually requires numerous truncated peptides or a reverse immunogenetic approach, where the peptide binding motif is used to predict epitopes. These binding motifs do not reliably predict all peptides which are CTL epitopes. Comparison of 24 peptides eluted from HLA-B8 with 10 HLA-B8-restricted defined CTL epitopes demonstrated that known epitopes varied considerably at anchor positions. We used structural information based on determination of the crystal structure of the HLA-B8-GGKKKYKL complex to reassess previously described CTL epitopes, to predict new epitopes, and to predict the consequences of naturally occurring variation within epitopes. These predictions were confirmed by cytotoxicity and binding assays. Use of combined structural and immunological data more accurately defines the true peptide-binding motif of a restriction element than eluted peptide data allows.
引用
收藏
页码:1515 / 1521
页数:7
相关论文
共 29 条
[1]   Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) [J].
Bunce, M ;
ONeill, CM ;
Barnardo, MCNM ;
Krausa, P ;
Browning, MJ ;
Morris, PJ ;
Welsh, KI .
TISSUE ANTIGENS, 1995, 46 (05) :355-367
[2]  
BURG SH, 1996, J IMMUNOL, V156, P3308
[3]   AN EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC T-CELL EPITOPE IN EBV NUCLEAR ANTIGEN-3 (EBNA-3) [J].
BURROWS, SR ;
SCULLEY, TB ;
MISKO, IS ;
SCHMIDT, C ;
MOSS, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :345-349
[4]   3-DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING FROM ONE END OF A CLASS-I MHC BINDING-SITE [J].
COLLINS, EJ ;
GARBOCZI, DN ;
WILEY, DC .
NATURE, 1994, 371 (6498) :626-629
[5]  
DIBRINO M, 1994, J IMMUNOL, V152, P620
[6]   An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide [J].
Dong, T ;
Boyd, D ;
Rosenberg, W ;
Alp, N ;
Takiguchi, M ;
McMichael, A ;
RowlandJones, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :335-339
[7]   Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection [J].
Goulder, PJR ;
Bunce, M ;
Krausa, P ;
McIntyre, K ;
Crowley, S ;
Morgan, B ;
Edwards, A ;
Giangrande, P ;
Phillips, RE ;
McMichael, AJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (18) :1691-1698
[8]   MOLECULAR ANALYSIS OF THE ASSOCIATION OF HLA-B53 AND RESISTANCE TO SEVERE MALARIA [J].
HILL, AVS ;
ELVIN, J ;
WILLIS, AC ;
AIDOO, M ;
ALLSOPP, CEM ;
GOTCH, FM ;
GAO, XM ;
TAKIGUCHI, M ;
GREENWOOD, BM ;
TOWNSEND, ARM ;
MCMICHAEL, AJ ;
WHITTLE, HC .
NATURE, 1992, 360 (6403) :434-439
[9]   IDENTIFICATION OF OVERLAPPING HLA CLASS I-RESTRICTED CYTOTOXIC T-CELL EPITOPES IN A CONSERVED REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN - DEFINITION OF MINIMUM EPITOPES AND ANALYSIS OF THE EFFECTS OF SEQUENCE VARIATION [J].
JOHNSON, RP ;
TROCHA, A ;
BUCHANAN, TM ;
WALKER, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :961-971
[10]  
JONES TA, 1985, METHOD ENZYMOL, V115, P157